Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis

Cancer and Metastasis Reviews

Volumn 14, Issue 4, 1995, Pages 351-362

  MacDougall, John R ^a   Matrisian, Lynn M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

collagenase; gelatinase; in situ hybridization; invasion; matrilysin; metastasis; MMP; stromelysin

Indexed keywords

COLLAGENASE; GELATINASE; MATRILYSIN; MATRIX METALLOPROTEINASE; STROMELYSIN;

CANCER; CANCER INVASION; IN SITU HYBRIDIZATION; METASTASIS; PRIORITY JOURNAL; REVIEW; STROMA; TUMOR GROWTH;

AMINO ACID SEQUENCE; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; STROMAL CELLS;

EID: 0029594498     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/BF00690603     Document Type: Article

References (84)

1. The matrix-degrading metalloproteinases
2. Matrix Metalloproteinases: A Review
3. Proteinases and extracellular matrix remodeling
4. Collagenolytic activity in amphibian tissues: a tissue culture assay
5. A matrix metalloproteinase expressed on the surface of invasive tumour cells
6. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys 73 active-site zinc complex in latency and a ‘cysteine switch’ mechanism for activation
7. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development
8. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer
9. Cytokine regulation of metalloproteinase gene expression
10. Isolation of the oncogene and epidermal growth factorinduced transin gene: Complex control in rat fibroblasts
11. Transcriptional and posttranscriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-betal in human fibroblasts: Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression
12. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts
13. Structure-function relationship of human neutrophil collagenase: Identification of regions responsible for substrate specificity and general proteinase activity
14. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
15. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-Ela
16. Mr92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells
17. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential
18. The 92 kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells
19. Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin
20. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas
21. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis
22. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma
23. MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production
24. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
25. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells
26. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo
27. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells
28. Inhibition of collagenolytic activity and metastatic of tumor cells by a recombinant human tissue inhibitor of metalloproteinases
29. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
30. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
31. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth
32. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
33. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo
34. Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice
35. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts
36. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
37. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas
38. Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing
39. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
40. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas
41. Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome
42. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization
43. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization
44. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas
45. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression
46. Expression of metalloproteinase genes in human prostate cancer
47. The metalloproteinase matrilysin is preferentially expressed in epithelial cells in a tissue-restricted pattern in the mouse
48. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium
49. Human fibroblast collagenase; complete primary structure and homology to an oncogene transformation-induced rat protein
50. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones
51. Multistage chemical carcinogenesis protocols produce spindle cell carcinomas of the mouse skin
52. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event
53. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression
54. A genetic analysis of extinction: trans-dominant loci regulate expression of liver-specific traits in hepatoma hybrid cells
55. Extinction of gene expression in somatic cell hybrids - a reflection of important regulatory mechanisms?
56. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c- fos and c- jun and activation of protein kinase C
57. Tumor cellderived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase
58. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells
59. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts
60. Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures
61. Tumor progression and the nature of cancer
62. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression
63. Reorganization of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in or on collagen gels
64. Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts
65. Constitutive production of 92 kDa gelatinase B can be suppressed by alterations in cell shape
66. Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases
67. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice
68. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells
69. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
70. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity
71. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
72. Tumor cell surface-associated binding site for the Mr 72,000 type IV collagenase
73. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells
74. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis
75. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
76. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: Inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2
77. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
78. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide
79. A metalloproteinase inhibitor as an inhibitor of neovascularization
80. Cellular markers that distinguish the phases of hemangioma during infancy and childhood
81. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy